192 related articles for article (PubMed ID: 38197667)
1. Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.
Wang B; Mao Z; Ye J; Jiao X; Zhang T; Wang Q; Han S; Zhang Y; Wang C; Dong T; Cui B
J Immunol; 2024 Feb; 212(4):723-736. PubMed ID: 38197667
[TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
3. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
[TBL] [Abstract][Full Text] [Related]
4. METTL14 regulates CD8
Sun C; Wang J; Li H; Liu L; Lin Y; Zhang L; Zu X; Zhu Y; Shu Y; Shen D; Wang Q; Liu Y
World J Surg Oncol; 2024 May; 22(1):128. PubMed ID: 38725005
[TBL] [Abstract][Full Text] [Related]
5. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.
Li L; Zeng J; He S; Yang Y; Wang C
Cancer Biol Ther; 2024 Dec; 25(1):2349429. PubMed ID: 38738555
[TBL] [Abstract][Full Text] [Related]
6. m
Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
[TBL] [Abstract][Full Text] [Related]
7. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
8. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
9. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
10. The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.
Xu Y; Yuan XD; Wu JJ; Chen RY; Xia L; Zhang M; Han CH; Mou S
J Cell Biochem; 2020 Jan; 121(1):524-533. PubMed ID: 31318098
[TBL] [Abstract][Full Text] [Related]
11. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
12. Aberrant METTL14 gene expression contributes to malignant transformation of benzene-exposed myeloid cells.
Wu C; Yu X; Li X; An R; Li S; Liu X; Hu X; Li S; Zhou Q; Li L; Yu H; Zhao M; Chang A
Ecotoxicol Environ Saf; 2024 May; 276():116302. PubMed ID: 38608381
[TBL] [Abstract][Full Text] [Related]
13. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
14. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
[TBL] [Abstract][Full Text] [Related]
15. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
[TBL] [Abstract][Full Text] [Related]
16. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.
Jian D; Wang Y; Jian L; Tang H; Rao L; Chen K; Jia Z; Zhang W; Liu Y; Chen X; Shen X; Gao C; Wang S; Li M
Theranostics; 2020; 10(20):8939-8956. PubMed ID: 32802173
[No Abstract] [Full Text] [Related]
17. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
18. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine modification of TSC1 mRNA contributes to macrophage polarization regulated by Coptisine in DSS-induced ulcerative colitis.
Zhao M; Li P; Qiao D; Hua S; Yue Q; Dai Y; Huang Y; Jiang J; Yin H; Li M; Ding Y; Yang X; Ma Y; Ding K; Zeng L
Phytomedicine; 2024 Jan; 122():155153. PubMed ID: 38014839
[TBL] [Abstract][Full Text] [Related]
20. Insights into roles of METTL14 in tumors.
Liu X; Du Y; Huang Z; Qin H; Chen J; Zhao Y
Cell Prolif; 2022 Jan; 55(1):e13168. PubMed ID: 34904301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
